Literature DB >> 19164250

Long-term intervention with heparins in a rat model of peritoneal dialysis.

Margot N Schilte1, Jesus Loureiro, Eelco D Keuning, Piet M ter Wee, Johanna W A M Celie, Robert H J Beelen, Jacob van den Born.   

Abstract

BACKGROUND: Peritoneal dialysis (PD) is associated with functional and structural alterations of the peritoneal membrane, particularly new vessel formation and fibrosis. In addition to anticoagulant effects, heparin displays anti-inflammatory and angiostatic properties. Therefore, the effects of administration of heparins on function and morphology of the peritoneal membrane were studied in a rat PD model.
METHODS: Rats received 10 mL conventional PD fluid (PDF) daily, with or without the addition of unfractionated heparin (UFH) or low molecular weight heparin (LMWH) in the PDF (1 mg/10 mL intraperitoneally) via a mini access port. Untreated rats served as controls. After 5 weeks, a 90-minute functional peritoneal transport test was performed and tissues and peritoneal leukocytes were taken.
RESULTS: PD treatment induced loss of ultrafiltration (p<0.01), a twofold increase in glucose absorption (p<0.03), increased urea transport (p<0.02), and loss of sodium sieving (p<0.03), which were also found in the PDF+heparin groups. Increased peritoneal cell influx and hyaluronan production (p<0.02) as well as an exchange of mast cells and eosinophils for neutrophils after PD treatment were observed in PD rats; addition of heparin did not affect those changes. Mesothelial regeneration, submesothelial blood vessel and matrix formation, and accumulation of tissue macrophages were seen in PD animals. Spindle-shaped vimentin-positive and cytokeratin-negative cells indicated either partial injury and denudation of mesothelial cells or epithelial-to-mesenchymal transition. Neither UFH nor LMWH affected any of these morphological changes.
CONCLUSION: Within 5 weeks, PD treatment induces a chronic inflammatory condition in the peritoneum, evidenced by high transport, leukocyte recruitment, tissue remodeling, and induction of spindle-shaped cells in the mesothelium. Addition of LMWH or UFH to the PDF did not prevent these adverse PDF-induced peritoneal changes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164250

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  10 in total

1.  The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.

Authors:  Yu-Pei Fan; Ching-Chih Hsia; Kuang-Wen Tseng; Chih-Kai Liao; Tz-Win Fu; Tsui-Ling Ko; Mei-Miao Chiu; Yang-Hsin Shih; Pei-Yu Huang; Yi-Chia Chiang; Chih-Ching Yang; Yu-Show Fu
Journal:  Stem Cells Transl Med       Date:  2015-12-30       Impact factor: 6.940

Review 2.  A review of rodent models of peritoneal dialysis and its complications.

Authors:  Ji Wang; Shujun Liu; Hongyu Li; Jing Sun; Sijin Zhang; Xiaohong Xu; Yingying Liu; Yangwei Wang; Lining Miao
Journal:  Int Urol Nephrol       Date:  2014-11-26       Impact factor: 2.370

3.  Bioincompatible impact of different peritoneal dialysis fluid components and therapeutic interventions as tested in a rat peritoneal dialysis model.

Authors:  Andrea W D Stavenuiter; Karima Farhat; Margot N Schilte; Piet M Ter Wee; Robert H J Beelen
Journal:  Int J Nephrol       Date:  2011-08-02

4.  Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1α, VEGF and TGF-β1.

Authors:  Juan Li; Zhi Yong Guo; Xian Hua Gao; Qi Bian; Meng Jia; Xue Li Lai; Tie Yun Wang; Xiao Lu Bian; Hai Yan Wang
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

Review 5.  Regulation of synthesis and roles of hyaluronan in peritoneal dialysis.

Authors:  Timothy Bowen; Soma Meran; Aled P Williams; Lucy J Newbury; Matthias Sauter; Thomas Sitter
Journal:  Biomed Res Int       Date:  2015-10-13       Impact factor: 3.411

6.  Changes in expression of four molecular marker proteins and one microRNA in mesothelial cells of the peritoneal dialysate effluent fluid of peritoneal dialysis patients.

Authors:  Lin Zhang; Fuyou Liu; Youming Peng; Lin Sun; Guochun Chen
Journal:  Exp Ther Med       Date:  2013-09-02       Impact factor: 2.447

7.  Protective Effects of Paricalcitol on Peritoneal Remodeling during Peritoneal Dialysis.

Authors:  Andrea W D Stavenuiter; Karima Farhat; Marc Vila Cuenca; Margot N Schilte; Eelco D Keuning; Nanne J Paauw; Pieter M ter Wee; Robert H J Beelen; Marc G Vervloet
Journal:  Biomed Res Int       Date:  2015-10-29       Impact factor: 3.411

8.  Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.

Authors:  Caigan Du; Asher A Mendelson; Qiunong Guan; Ghida Dairi; Irina Chafeeva; Gerald da Roza; Jayachandran N Kizhakkedathu
Journal:  J Transl Med       Date:  2016-12-13       Impact factor: 5.531

9.  Differences in peritoneal response after exposure to low-GDP bicarbonate/lactate-buffered dialysis solution compared to conventional dialysis solution in a uremic mouse model.

Authors:  M Vila Cuenca; E D Keuning; W Talhout; N J Paauw; F J van Ittersum; P M Ter Wee; R H J Beelen; M G Vervloet; E Ferrantelli
Journal:  Int Urol Nephrol       Date:  2018-05-04       Impact factor: 2.370

10.  SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-β/Smad3 pathway.

Authors:  Yanhong Guo; Liuwei Wang; Rong Gou; Yulin Wang; Xiujie Shi; Xinxin Pang; Lin Tang
Journal:  Stem Cell Res Ther       Date:  2020-08-18       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.